Percutaneous mitral repair: current and future devices

Mitral regurgitation (MR) is the second most common valvular heart disease and its prevalence is increasing with population ageing. In the recent years we have witnessed the development of several transcatheter devices to correct MR in patients at high-risk for surgery. The majority of evidence rega...

Descripción completa

Detalles Bibliográficos
Autores principales: Estévez-Loureiro, Rodrigo, Benito-González, Tomás, Garrote-Coloma, Carmen, Fernández-Vázquez, Felipe, Avanzas, Pablo, Piñón, Miguel, Pascual, Isaac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article on Structural Heart Disease: The Revolution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475444/
https://www.ncbi.nlm.nih.gov/pubmed/32953763
http://dx.doi.org/10.21037/atm.2020.03.154
Descripción
Sumario:Mitral regurgitation (MR) is the second most common valvular heart disease and its prevalence is increasing with population ageing. In the recent years we have witnessed the development of several transcatheter devices to correct MR in patients at high-risk for surgery. The majority of evidence regarding safety and efficacy of this new therapy comes from MitraClip studies. However, new alternatives on the field of valve repair have emerged with promising results. The aim of this review is to portrait the landscape of transcatheter mitral repair alternatives, from currently used devices to those that will have a role in the near future.

Ejemplares similares